Categories: HealthcareNews

Sofwave Medical to Participate in the Oppenheimer 33rd Annual Healthcare Conference

SAN CLEMENTE, Calif., March 07, 2023 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Oppenheimer 33rd Annual Healthcare Conference, to be held virtually from March 13-15, 2023.

Oppenheimer 33rd Annual Healthcare Conference
Format: Corporate update and one-on-one investor meetings
Presentation Date: Tuesday, March 14, 2023
Presentation Time: 8:40 a.m. ET
Webcast: Click Here

About

Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue and the short term improvement in the appearance of cellulite providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: Info@sofwave.com

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
britchie@lifesciadvisors.com

Staff

Recent Posts

Nauticus Robotics Announces Timing of 2024 Investor Earnings Conference Call

HOUSTON, April 11, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. ("Nauticus" or "Company") (NASDAQ: KITT) today…

3 hours ago

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation…

9 hours ago

STAGO ANNOUNCES “THE IMPORTANCE OF ROUTINE COAGULATION TESTING” EDUCATIONAL WEBINAR

PARSIPPANY, N.J., April 11, 2025 /PRNewswire/ -- Diagnostica Stago, Inc., a global leader in hemostasis…

9 hours ago

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

The Company Expects the Continued Sale of OPKO-Branded Products in China but is Pausing Activities…

9 hours ago

Hamamatsu Photonics and Sirona Dx (SDX) Announce Strategic Partnership to Expand Technology Access Program (TAP)

BRIDGEWATER, N.J., April 11, 2025 /PRNewswire/ -- Hamamatsu Photonics, a global leader in whole slide…

9 hours ago

ProviderTrust Celebrates 15 Years of Innovation and Looks Ahead to the Future of Provider Data

NASHVILLE, Tenn., April 11, 2025 /PRNewswire/ -- Entering its 15th year, ProviderTrust continues to lead…

9 hours ago